OSX
vs
S
S&P/ASX 300
OSX
Over the past 12 months, OSX has underperformed S&P/ASX 300, delivering a return of -81% compared to the S&P/ASX 300's +6% growth.
Stocks Performance
OSX vs S&P/ASX 300
Performance Gap
OSX vs S&P/ASX 300
Performance By Year
OSX vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Osteopore Ltd
Glance View
Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-09-23. The firm is engaged in commercializing a range of products to facilitate bone healing across multiple therapeutic areas. The company fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material using its platform technology. Its 3D print scaffold design is based on the principle of tissue engineering and regenerative medicine. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. Its craniofacial products are used as bone void fillers for regeneration of natural bone. The company also develops and manufactures implants that focuses on unmet clinical needs which improve patient outcomes. Its science of tissue engineering and regenerative medicine provides various surgical solutions for medical surgeons. Its products are used by surgeons across Asia, Europe, Australia, and the Americas.